导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.61% | 347/1050 |
| 近一周 | -2.83% | 731/1104 |
| 近一月 | -3.86% | 508/1102 |
| 近一季 | -3.14% | 492/1092 |
| 近半年 | -5.52% | 657/1070 |
| 近一年 | 4.69% | 499/1018 |
| 近两年 | 74.20% | 338/926 |
| 近三年 | 34.27% | 366/833 |
| 成立以来 | 71.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.72% 73/1070 |
9.02% 561/1101 |
- - |
- - |
| 2025 | 24.03% 599/1065 |
-1.17% 868/1014 |
1.57% 544/1038 |
33.60% 307/1050 |
-7.52% 818/1065 |
| 2024 | 5.04% 424/1011 |
-13.55% 877/960 |
2.01% 197/983 |
15.38% 211/991 |
3.23% 195/1011 |
| 2023 | -15.36% 536/952 |
10.60% 100/880 |
-10.07% 773/895 |
-13.23% 737/915 |
-1.92% 225/952 |
| 2022 | -23.99% 465/867 |
-5.40% 38/773 |
-3.56% 747/806 |
-14.97% 563/845 |
-2.01% 540/867 |
| 2021 | 21.78% 147/740 |
-2.23% 232/580 |
1.14% 531/659 |
11.42% 50/704 |
10.54% 72/740 |
| 2020 | 47.92% 246/554 |
2.08% 111/419 |
13.28% 374/466 |
13.99% 163/517 |
12.23% 284/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 湘财长源股票型C VS. 东吴新产业精选股票A(580008) |